tiprankstipranks
Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
PremiumThe FlyPiper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’
1M ago
Immunome initiated with a Buy at Lake Street
Premium
The Fly
Immunome initiated with a Buy at Lake Street
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
PremiumRatingsImmunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
3M ago
Immunome’s 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Immunome’s 2024 Financial Results and Pipeline Progress
3M ago
Immunome price target lowered to $25 from $35 at Guggenheim
Premium
The Fly
Immunome price target lowered to $25 from $35 at Guggenheim
3M ago
Immunome $125M Spot Secondary; price range $7.50-$8.00
PremiumThe FlyImmunome $125M Spot Secondary; price range $7.50-$8.00
4M ago
Immunome announces $125M common stock offering
Premium
The Fly
Immunome announces $125M common stock offering
4M ago
Immunome CFO Relocation and Compensation Package Unveiled
Premium
Company Announcements
Immunome CFO Relocation and Compensation Package Unveiled
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100